Pacira BioSciences (PCRX) Operating Income (2010 - 2026)
Pacira BioSciences (PCRX) reported Operating Income of $4.27 million for Q2 2026, down 49.8% from $8.5 million a year earlier and down 38.2% from the prior quarter.
Pacira BioSciences (PCRX) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Operating Income came in at $19.87 million; for FY2025, it came in at $19.19 million.
- Operating Income has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- By year, Operating Income came in at -$73.37 million in FY2024, $87.68 million in FY2023 (+46.1%), $60.02 million in FY2022 (-33.3%) and $89.92 million in FY2021 (+94.0%).
- Five-year quarterly Operating Income spans a low of -$139.53 million in Q3 2024 and a high of $39.88 million in Q2 2023.
- Year over year, Operating Income gained in 1 of the last six quarters, with an average decline of 12.3%.
- The high point for year-over-year Operating Income in five years was Q1 2026 (growth of 246.8%); the low point was Q4 2025 (a decline of 90.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.9 million (Q1 2026), $2.34 million (Q4 2025) and $6.36 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn | 4.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 24.70 Mn |
| Sep 30, 2024 | -139.53 Mn |
| Jun 30, 2024 | 28.24 Mn |
| Mar 31, 2024 | 13.21 Mn |
| Dec 31, 2023 | 33.17 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 39.88 Mn |
| Mar 31, 2023 | -3.09 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | 21.29 Mn |
| Jun 30, 2022 | 31.24 Mn |
| Mar 31, 2022 | 17.39 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 31.43 Mn |
Pacira BioSciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();